Search results
NIH launches 2 clinical trials testing HIV drug on women, other minority groups
UPI· 3 days agoJune 4 (UPI) -- The National Institutes of Health on Tuesday said they are seeking to now include...
Ensysce Biosciences Announces Major Milestone for Opioid Use Disorder Program
Digital Journal· 2 days agoThis work has been supported by a multi-year Helping to End Addiction Long-Term (HEAL) award of up to $15 million granted by the NIH and National Institute
A club drug could be the next big thing in treating mental illness
Politico via Yahoo News· 3 days agoBut there’s a problem with the rosy forecasts. Lykos has come under fire for allegedly slanting its studies to make the case for approval. The head of the National
Drug-related deaths dropped in Knox and Anderson County last year, but there’s still concerns
WVLT-TV Knoxville· 1 day agoThursday, the Knox County Forensic Center released its 2023 drug-related death report, outlining...
White House's New Opioid Overdose Initiative Hits Home For One MLB Team
Newsweek· 10 hours agoWhen the White House announced a new initiative Tuesday aimed at preventing opioid overdoses, one...
U.S. Clinical Trials Begin for Twice-Yearly HIV Prevention Injection, NIH Reports
Sierra Sun Times· 1 day agoStudies will focus on priority populations underrepresented in HIV clinical research. June 6, 2024 –...
How opioid prescriptions to Medicaid patients in Florida stack up
WKMG ClickOrlando· 2 days agoAccording to the National Institute on Drug Abuse, overdose fatalities that involved opioids...
An FDA panel just rejected using MDMA to treat PTSD. Here are 5 things to know about the psychedelic...
Yahoo Life Style via AOL· 2 days agoMDMA, also known as ecstasy, is seen by some experts as a potential breakthrough treatment for PTSD,...
Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocates
WROC Rochester· 3 days agoWASHINGTON (AP) — A first-of-a-kind proposal to begin using the mind-altering drug MDMA as a...
Ensysce Biosciences Announces Major Milestone for Opioid Use Disorder Program
Morningstar· 2 days agoDesigned with the application of Ensysce's TAAP platform to reduce the abuse profile, lead candidate PF9001 has shown lower potential for cardiovascular side effects associated ...